|
LOC400657 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.991000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.229800E-01 |
| Normal-vs-Stage2 |
8.712400E-01 |
| Normal-vs-Stage3 |
5.592500E-02 |
| Normal-vs-Stage4 |
6.438200E-01 |
| Stage1-vs-Stage2 |
9.621800E-01 |
| Stage1-vs-Stage3 |
5.883900E-02 |
| Stage1-vs-Stage4 |
7.415400E-01 |
| Stage2-vs-Stage3 |
1.548570E-01 |
| Stage2-vs-Stage4 |
7.168600E-01 |
| Stage3-vs-Stage4 |
4.480200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.085200E-01 |
| Normal-vs-AfricanAmerican |
8.333800E-01 |
| Normal-vs-Asian |
1.970360E-01 |
| Caucasian-vs-AfricanAmerican |
9.500600E-01 |
| Caucasian-vs-Asian |
2.339200E-01 |
| AfricanAmerican-vs-Asian |
2.081800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.585800E-01 |
| Normal-vs-Female |
2.932600E-01 |
| Male-vs-Female |
3.460600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.407000E-01 |
| Normal-vs-Extreme_Weight |
6.424000E-01 |
| Normal-vs-Obese |
8.491000E-01 |
| Normal-vs-Extreme_Obese |
8.259200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.520800E-01 |
| Normal_Weight-vs-Obese |
8.822600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.972800E-01 |
| Extreme_Weight-vs-Obese |
8.184800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.703600E-01 |
| Obese-vs-Extreme_Obese |
9.305000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.221400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.406800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.157600E-01 |
| Normal-vs-Age(81-100Yrs) |
6.522800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.317200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.166200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.522600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.997800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.953800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.007000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.626200E-02 |
| Normal-VS-Type2 PRCC |
1.60867999999814E-05 |
| Normal-VS-KIRP CIMP |
5.955100E-03 |
| Normal-VS-Unclassified PRCC |
4.619200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.41979991599806E-10 |
| Type1 PRCC-VS-KIRP CIMP |
1.464130E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.011600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.392000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.869880E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.558150E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.234820E-01 |
| Normal-vs-N1 |
4.242000E-02 |
| Normal-vs-N2 |
5.609200E-04 |
| N0-vs-N1 |
4.099200E-01 |
| N0-vs-N2 |
1.053020E-01 |
| N1-vs-N2 |
2.243800E-01 |
|
|
